Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 2 July 2020

 
 
 
   

EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now

 
Parliament Magazine

When the Roadmap to the EU’s Pharmaceutical strategy was announced by Health Commissioner Stella Kyriakides, she underlined that “The EU needs a pharmaceutical strategy that makes essential medicines available to all and cements our global leadership on innovation in pharmaceuticals”. Now more than ever before, the COVID-19 crisis has shown that the world looks to medical innovation to fight global health threats and to tackle our existing health challenges. In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery. Read more


 
 
 
   

News

 

Time to act together: patients wait more than 6 times longer for access to new medicines in...
02 July 2020

The EFPIA Patients WAIT Survey and the EFPIA/CRA analysis should serve as a starting point for an informed discussion... Read more

EFPIA announces new members at a critical time for European healthcare and the research-based...
30 June 2020

EFPIA welcomes Stallergenes Greer Ltd and Gilead Sciences as new members of EFPIA, as well as 14 new SME members and... Read more

 
 
 
   

Blogs

 

Make the regulatory system fit for the future of medical innovation
30 June 2020 - Nathalie Moll

The “new normal” in regulatory terms should aim at decreasing complexity while ensuring the quality, safety and efficacy... Read more

ICH - Instilling ‘harmony’ for 30 years, and never more relevant than today!
29 June 2020 - Pär Tellner

Harmonisation of requirements for drug development and manufacturing will contribute to the objective of safe, effective... Read more

 
 
 
   

Videos

 

Keep the Spark Alive: the Regulatory Road to Innovation
Europe’s regulatory system is designed to ensure that new treatments for patients are safe and effective. It has... Read more

Treatment Outcomes 2020/30
This international conference, organized under the patronage of the Presidency of the Council of the European Union,... Read more

 
 
 
   

Our latest publications

 

The pharmaceutical industry: a key asset to medical progress and the European economy
30 June 2020 (Publications)

Our annual statistics leaflet Read more

EFPIA Patients W.A.I.T. Indicator 2019 Survey
01 July 2020 (Publications)

The yearly EFPIA Patients WAIT survey is now published Read more

The root causes of unavailability and delay to innovative medicines
01 July 2020 (Publications)

Analysis developed with the support of Charles Rivers Associates (CRA) Read more

 
 
 
   

What we are reading

 

IMI-supported Ebola vaccine regimen gets green light
On 01 July 2020 (IMI website)

The European Commission has officially granted market authorisation for an IMI-supported Ebola vaccine regimen, which... Read more